BioMerieux rebounds from 1.5-year lows as 2026 forecasts reassure

Biomerieux SA

27/02/2026 09:36

** Shares in France's bioMerieux BIOX.PA rise over 5%, paring YTD losses which sent the stock near July 2024 lows, after the in-vitro diagnostics group provided reassuring 2026 guidance

** There is potential for some relief considering sentiment and the company's price action, a trader says

** The company expects its 2026 sales to grow 5-7% LFL, contributive operating income to increase by at least 10%

** Forecasts are in line with the company's strategic plan to 2028, TP ICAP Midcap says, adding cash generation was solid last year

** bioMerieux shares on track for a best day since late August 2024

** Including Friday's rise, the stock has dropped by 8% YTD​

($1 = 0.8472 euros)

 (Reporting by Alessandro Parodi)

 ((Alessandro.Parodi@thomsonreuters.com;))